Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Kantartzis, J. Machann, F. Schick, A. Fritsche, H. Häring, N. Stefan (2010)
The impact of liver fat vs visceral fat in determining categories of prediabetesDiabetologia, 53
T. McLaughlin, F. Abbasi, C. Lamendola, G. Reaven (2007)
Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity.Archives of internal medicine, 167 7
R. Wildman, P. Muntner, K. Reynolds, A. Mcginn, S. Rajpathak, J. Wylie-Rosett, M. Sowers (2008)
The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).Archives of internal medicine, 168 15
N. Stefan, K. Kantartzis, H. Häring (2008)
Causes and metabolic consequences of Fatty liver.Endocrine reviews, 29 7
Gianluca Perseghin (2008)
Is a nutritional therapeutic approach unsuitable for metabolically healthy but obese women?Diabetologia, 51
M. Matsuda, R. DeFronzo (1999)
Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.Diabetes care, 22 9
G. Calori, G. Lattuada, L. Piemonti, M. Garancini, F. Ragogna, M. Villa, S. Mannino, P. Crosignani, E. Bosi, L. Luzi, G. Ruotolo, G. Perseghin (2010)
Prevalence, Metabolic Features, and Prognosis of Metabolically Healthy Obese Italian IndividualsDiabetes Care, 34
G. Perseghin, A. Karelis, V. Messier, M. Brochu, R. Rabasa‐Lhoret (2008)
Metabolically healthy but obese women: effect of an energy-restricted dietDiabetologia, 51
K. Kantartzis, C. Thamer, A. Peter, J. Machann, F. Schick, C. Schraml, A. Königsrainer, I. Königsrainer, Stefan Kröber, A. Niess, A. Fritsche, Hans Häring, N. Stefan (2008)
High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver diseaseGut, 58
A. Karelis (2008)
Metabolically healthy but obese individualsThe Lancet, 372
J. Meigs, P. Wilson, C. Fox, R. Vasan, D. Nathan, L. Sullivan, R. D'Agostino (2006)
Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease.The Journal of clinical endocrinology and metabolism, 91 8
B. Arsenault, M. Côté, A. Cartier, I. Lemieux, J. Despres, R. Ross, C. Earnest, S. Blair, T. Church (2009)
Effect of exercise training on cardiometabolic risk markers among sedentary, but metabolically healthy overweight or obese post-menopausal women with elevated blood pressure.Atherosclerosis, 207 2
N. Stefan, K. Kantartzis, J. Machann, F. Schick, C. Thamer, K. Rittig, B. Balletshofer, F. Machicao, A. Fritsche, H. Häring (2008)
Identification and characterization of metabolically benign obesity in humans.Archives of internal medicine, 168 15
D. Matthews, J. Hosker, A. Rudenski, B. Naylor, D. Treacher, R. Turner (1985)
Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 28
G Calori, G Lattuada, L Piemonti (2010)
Prevalence, metabolic features and prognosis of metabolically healthy obese Italian individuals: the Cremona StudyDiabetes Care
Min-Jeong Shin, Y. Hyun, O. Kim, Jiyoo Kim, Yangsoo Jang, Jae-Bum Lee (2006)
Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO womenInternational Journal of Obesity, 30
(1998)
Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. National Institutes of HealthObes Res, 6
N. Klöting, M. Fasshauer, A. Dietrich, P. Kovacs, M. Schön, Matthias Kern, M. Stumvoll, M. Blüher (2010)
Insulin-sensitive obesity.American journal of physiology. Endocrinology and metabolism, 299 3
IS improves during the lifestyle intervention in OIR individuals. However, it does not reach a level where adequate protection from type 2 diabetes and cardiovascular disease is expected. Thus, stratification of obese individuals based on their metabolic phenotype is important to identify those who are likely to need early pharmacological treatment in addition to the lifestyle intervention.
Diabetologia – Springer Journals
Published: Apr 1, 2011
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.